Related Experiment Video
Updated: Jun 28, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
[Clinical characteristics of pertussis in hospitalized children under 3 months]
1Department of Neonatal Medicine, Affiliated Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China.
Insights
Infants under 3 months with pertussis (whooping cough) face significantly higher risks of severe pneumonia and respiratory complications. Early diagnosis and intervention are crucial for this vulnerable age group to improve outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Context:
- Pertussis (whooping cough) remains a significant public health concern, particularly for infants.
- Clinical presentation and severity of pertussis can vary with age, necessitating age-specific risk assessments.
- Understanding the clinical characteristics of pertussis in young infants is crucial for timely diagnosis and management.
Purpose:
- To retrospectively analyze the clinical data of hospitalized pertussis patients.
- To compare the incidence of severe pertussis and related complications between infants younger than 3 months and those 3 months or older.
- To identify specific clinical manifestations and risk factors associated with severe pertussis in infants under 3 months.
Summary:
- A retrospective study of 270 hospitalized pertussis patients (March 2011-February 2023) found infants under 3 months (n=143) had significantly higher rates of severe pneumonia (21.0% vs 7.9%) and severe pertussis (38.5% vs 11.0%) compared to older infants (n=127).
- Younger infants (<3 months) exhibited increased incidence of paroxysmal cough with vomiting (25.2% vs 10.2%), cyanosis (38.5% vs 15.7%), apnea (7.0% vs 1.6%), hypoxemia (36.4% vs 10.2%), and respiratory failure (16.8% vs 7.1%).
- These findings highlight that infants under 3 months are particularly vulnerable to severe pertussis and its complications, including respiratory distress and failure.
Impact:
- The study underscores the critical need for heightened vigilance and prompt medical attention for pertussis in infants under 3 months.
- Results can inform clinical guidelines and public health strategies for pertussis prevention and management in vulnerable infant populations.
- Early identification of severe pertussis symptoms in young infants can lead to timely interventions, potentially reducing morbidity and mortality.
Abstract:
Demographic data and clinical data were collected retrospectively from patients with pertussis at the Children's Hospital Affiliated to the Capital Institute of Pediatrics between March 2011 and February 2023. Among the 270 hospitalized patients, 151 cases were male and 119 were female. The youngest age of admission was 10 days and the eldest age of admission was 11 years. The 270 hospitalized patients were divided into two groups according to onset age: <3 months (n=143) and≥3 months (n=127). For those in the <3-month-old group, the incidence of severe pneumonia and severe pertussis were 21.0% and 38.5%, respectively, both were significantly higher than those in≥3-month-old group (7.9% and 11.0%, both P<0.05). For those in the <3-month-old group, paroxysmal spasmodic cough, post-tussive vomiting, paroxysmal cyanosis, apnea, and decreased heart rate after coughing were 86.7%, 25.2%, 38.5%, 7.0% and 16.8%, respectively, all were significantly higher than those in ≥3-month-old group (76.4%, 10.2%, 15.7%, 1.6% and 1.6%, all P<0.05). For those in the<3-month-old group, the incidence of hypoxemia, respiratory failure, were 36.4%, 16.8%, respectively, and both were significantly higher than those in≥3-month-old group (10.2%, 7.1%, P<0.05). It indicated that among the infants under 3 months, the incidence of vomiting after coughing, paroxysmal cyanosis, apnea, hypoxemia, respiratory failure, decreased heart rate after coughing and severe pneumonia were significantly higher than those above 3 months. Infants under 3 months were prone to severe pertussis.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-IV
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: